ERBB2 and breast carcinoma: Therefore, the aim of this study was to investigate whether the utilization of a rapid and reproducible approach of VOI-based semi-automatic radiomics can facilitate the prediction of the molecular subtype, hormonal receptor status, Ki67- and HER2-Expression, involvement of lymph nodes and lymph vessel involvement as well as grading in patients with breast cancer.